Skip to main content

Table 1 RB1 status of 30 cancer cell lines used for gene expression

From: Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples

Cell line

Tissue type

RB1 genetic status

RB1 functional status

T-24

bladder

wild-type

+

U-2-OS

bone

wild-type

+

SF268

CNS

wild-type

+

DLD-1

colon

NA

+

HCT-116

colon

wild-type

+

Hep G2

liver

NA

+

NCI-H460

NSCLC

wild-type

+

A549

NSCLC

wild-type

+

UACC-62

melanoma

wild-type

+

MDAH-2774

ovary

NA

+

PANC-1

pancreas

NA

+

SU.86.86

pancreas

NA

+

NCI-N87

stomach

wild-type

+

Hs 746T

stomach

NA

+

KATOIII

stomach

wild-type

+

SCC-25

tongue

wild-type

+

J82

tongue

Δ21 2107-2A > G

-

HeLa S3

bladder

repressed by E7

-

DU-145

cervix

stop: K175*

-

TCCSUP

bladder

deletion: 1696_2787del1092

-

MDA-MB-436

breast

frame shift: G203fs*8

-

MDA-MB-468

breast

deletion: 265_2787del2523

-

SF-539

CNS

deletion: T116fs*8

-

HeLa

cervix

repressed by E7

-

C-33A

cervix

deletion: 4aa in exon2

-

Lu-135

SCLC

frame shift: R661fs*1

-

NCI-H128

SCLC

frame shift: R418fs*2

-

NCI-H1417

SCLC

stop: Y321*

-

NCI-H69

SCLC

stop: E748*

-

NCI-H596

NSCLC

frame shift: R661fs*1

-

  1. *The functional assay which determined the status of RB1 in the present study is described in Methods and data are shown in Additional file 1.